ATAI Life Sciences NV (9VC)
TG
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 9VC market cap is 224.41M. The company's latest EPS is USD -0.2403 and P/E is -6.16.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 20.38M | 233k | 314k |
| Operating Income | -17.23M | -104.58M | -135.63M | -141.83M | -125.41M |
| Net Income | -14.14M | -169.84M | -167.81M | -152.39M | -40.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 62.12M | 111.55M | 414.17M | 305.44M | 293.48M |
| Total Liabilities | 2.48M | 16.18M | 28.21M | 39.68M | 49.16M |
| Total Equity | 59.64M | 95.37M | 385.96M | 265.77M | 244.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.85M | -20.77M | -63.25M | -104.47M | -84.12M |
| Investing | -9.03M | -28.27M | -81.28M | -86.85M | -53.3M |
| Financing | 40.39M | 113.05M | 409.86M | 20.79M | -8.36M |
| Market Cap | 224.41M |
| Price to Earnings Ratio | -6.16 |
| Price to Sales Ratio | 778.95 |
| Price to Cash Ratio | 5.5 |
| Price to Book Ratio | 1.01 |
| Dividend Yield | - |
| Shares Outstanding | 167.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (3.8%) |
| Company Name | ATAI Life Sciences NV |
| Address |
wallstrabe 16 berlin 10179 |
| Website | https://www.atai.life |
| Industry | intermediate care facilities (8052) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
